Prognosis of diabetic nephropathy: How to improve the outcome

Diabetes Research and Clinical Practice

Volumn 39, Issue SUPPL., 1998, Pages

  Remuzzi, Giuseppe ^a,b   Ruggenenti, Piero ^a,b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b Azienda Ospedaliera Ospedali R   (Italy)

Author keywords

Angiotensin converting enzyme; Diabetic nephropathy; Normoalbuminuria

Indexed keywords

CALCIUM ANTAGONIST; CAPTOPRIL; CLOTIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; RAMIPRIL; TRANDOLAPRIL; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HUMAN; MICROALBUMINURIA;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; PROGNOSIS;

EID: 0031801591     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00016-3     Document Type: Article

References (18)

1. Remuzzi G., Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int. 38:1990;384.
2. Klahr S., Schreiner G., Ichikawa I. The progression of renal disease. New Engl. J. Med. 318:1988;1657-1666.
3. Hostetter T.H., Olson J.L., Rennke H.G., Venkatachalam M.A., Brenner B.M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 241:1981;85.
4. Olson J.L., Hostetter T.H., Rennke H.G., Brenner B.M., Venkatachalam M.A. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int. 22:1982;112-126.
5. Remuzzi G., Ruggenenti P., Benigni A. Understanding the nature of renal disease progression. Kidney Int. 51:1997;2-15.
6. Kasiske B.L., Kalil R.S.N., Ma J.Z., Liao M., Keane W.F. Effects of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann. Intern. Med. 118:1993;129.
7. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1993;1456.
8. Myers B.D., Nelson R.G., Tan M., Beck G.J., Bennett P.H., Knowler W.C., Blouch K., Mitch W.E. Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int. 4:1995;1781-1789.
9. Mathiesen E.R., Hommel E., Smidt U.M., Parving H. Efficacy of captopril in normotensive diabetic patients with microalbuminuria-8 years follow-up. J. Am. Soc. Nephrol. 6(3):1995;452. Abstract.
10. Viberti G., Mogensen C.E., Groop L.C., Pauls J.F. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetic patients and microalbuminuria. J. Am. Med. Assoc. 271:1994;275-279.
11. Laffel L.M.B., McGill J.B., Gans D.J. On behalf of the North American Microalbuminuria Study Group. Am J Med. 99:1995;497-504.
12. Ravid M., Lang R., Rachmani R., Lishner M. Long-term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin dependent diabetes mellitus. Arch. Intern. Med. 156:1996;286-289.
13. Trevisan R., Tiengo A. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin dependent diabetic patients. Am. J. Hypertens. 8:1995;876-883.
14. Lebovitz H.E., Weigmann T.B., Cnaan A., Shahinfar S., Sica D.A., Broadstone V., Schwartz S.L., Mengel M.C., Segal R., Versaggi J.A., Bolton K.W. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int. 45:1994;150.
15. Brown S., Walton C., Crawford P., Bakris G.L. Comparative renal hemodynamic effects of an ACE-inhibitor or calcium antagonist on progression of diabetic nephropathy in the dog. Kidney Int. 43:1993;1210-1218.
16. Fioretto P., Frigato F., Velussi M., Riva F., Muollo B., Carraro A., Brocco E., Cipollina M.R., Abaterusso C., Trevisan M., Crepaldi G., Nosadini R. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am. J. Hypertens. 5:1992;837-846.
17. Bakris G., Barnhill B.W., Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int. 41:1992;912-919.
18. Gaspari F., Perico N., Ruggenenti P., Mosconi L., Amuchastegui C.S., Guerini E., Daina E., Remuzzi G. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate in patients with normal or impaired renal function. J. Am. Soc. Nephrol. 6:1995;1-7.